Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED

NCT04485533 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DEVICE: VisuXL® Gel
DEVICE: HYLO®

Sponsor

VISUfarma SpA